At a glance
- Originator Bristol-Myers Squibb
- Class Antivirals
- Mechanism of Action HIV protease inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 20 Dec 1999 No-Development-Reported for HIV infections treatment in USA (unspecified route)
- 13 Oct 1995 Phase-I clinical trials for HIV infections treatment in USA (unspecified route)